Self-Assembled Gefitinib Nanosuspension Prepared via Hummer Acoustic Resonance Technology: Enhanced Dissolution, In Vitro Anticancer Activity and Long-Term Stability
Pharmaceutics · 11.03.2026 · 18 (3) · 343
DOI: 10.3390/pharmaceutics18030343 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 11.03.2026. Verfasst von Hai-Li Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Traditional Chinese and Zhuang-Yao Ethnic Medicine, College of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530200, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangxi Science and Technology Program, Guangxi University of Chinese Medicine "Qihuang Project" High-level Talent Team Cul-tivation Programme.
Abstract (Originalsprache)
Background
Gefitinib (Gef) is a first-line epidermal growth factor receptor (EGFR) inhibitor for NSCLC, but its clinical application is limited by poor aqueous solubility and low oral bioavailability.
Methods
A self-assembled gefitinib nanosuspension (GG-NS) incorporating genistein (Gen) was rapidly developed and optimized via hammer acoustic resonance (HAR) technology. Systematic optimization was conducted using a high-throughput HAR-based process, with particle size, PDI, and zeta potential as key evaluation parameters. Structural and morphological characteristics were analyzed using powder X-ray diffraction (PXRD), thermal analysis, transmission electron microscopy (TEM), and Fourier-transform infrared (FT-IR) spectroscopy. In vitro dissolution behavior and cytotoxicity against A549 lung cancer cells were evaluated.
Results
Optimal GG-NS with Z-Ave = 223.50 ± 1.53 nm, PDI = 0.239 ± 0.031 and zeta potential = −24.10 ± 0.47 mV was successfully prepared. The nanosuspension remained physically stable for up to five months at both 4 °C and 25 °C. Compared with the raw drugs, GG-NS enhanced the dissolution of gefitinib and genistein in water by 3.76-fold and 13-fold, respectively. In addition, GG-NS showed significantly enhanced cytotoxicity against A549 cells, with a 33.8% higher inhibition rate than the physical mixture after 72 h.
Conclusions
This study demonstrates, for the first time, that HAR technology enables the rapid fabrication of a self-assembled GG-NS with improved dissolution performance, physicochemical stability, and in vitro anticancer activity, highlighting its promise as an efficient and scalable formulation strategy for poorly soluble anticancer drugs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Traditional Chinese and Zhuang-Yao Ethnic Medicine, College of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530200, China.
- Guangxi Innovation Center of Zhuang Yao Medicine, Nanning 530200, China.
Förderung
- National Natural Science Foundation of China
- Guangxi Science and Technology Program
- Guangxi University of Chinese Medicine "Qihuang Project" High-level Talent Team Cul-tivation Programme
- Gui Style Xinglin Top Talent Funding Project of Guangxi University of Chinese Medicine
- Guangxi University of Chinese Medicine “Qihuang Project” High-level Talent Team Cultivation Programme
Zitieren
APA
Wu, H. L., Wen, R. Y., Chen, L., Hu, Z. L., Qin, B. Y., Chen, J. F., Liu, M. H., Huang, X. Q., Lin, N., & Chen, Q. (2026). Self-Assembled Gefitinib Nanosuspension Prepared via Hummer Acoustic Resonance Technology: Enhanced Dissolution, In Vitro Anticancer Activity and Long-Term Stability. Pharmaceutics, 18(3), 343. https://doi.org/10.3390/pharmaceutics18030343
Vancouver
Wu HL, Wen RY, Chen L, Hu ZL, Qin BY, Chen JF, et al. Self-Assembled Gefitinib Nanosuspension Prepared via Hummer Acoustic Resonance Technology: Enhanced Dissolution, In Vitro Anticancer Activity and Long-Term Stability. Pharmaceutics. 2026;18(3):343. doi:10.3390/pharmaceutics18030343
BibTeX
@article{Wu2026,
author = {Wu, Hai-Li and Wen, Ru-Yan and Chen, Ling and Hu, Zhen-Long and Qin, Bao-Yi and Chen, Jie-Feng and Liu, Meng-Hua and Huang, Xuan-Qi and Lin, Ning and Chen, Qing},
title = {Self-Assembled Gefitinib Nanosuspension Prepared via Hummer Acoustic Resonance Technology: Enhanced Dissolution, In Vitro Anticancer Activity and Long-Term Stability},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {3},
pages = {343},
doi = {10.3390/pharmaceutics18030343}
}
EUVIMED